Project Grant R44HL186085
Award Date 9/1/26
Completion Date 5/31/28
Dollars Obligated $1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55414, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded Resuscitation Innovations LLC $396,098 on August 10, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and test an adjustable-pressure impedance threshold device for cardiac arrest resuscitation and post-resuscitation care. The recipient will refine the design of the Adjustable Pressure for Emergency Care (APEC) device, a dual-setting airway device with selectable cracking pressures of -6 and -12 centimeters of...
- The National Institute for Minority Health and Health Disparities awarded Innovative Design Labs Inc. $3,093,181 on September 23, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop a modular simulator for venipuncture, peripheral intravenous catheter, and injection training that represents the diversity of patients encountered in U.S. healthcare settings. Current IV skill trainers simulate primarily healthy adult anatomy, creating gaps in...
- The National Institute on Aging awarded Innovative Design Labs Inc. $313,311 on September 20, 2025, under the Aging Research program (CFDA 93.866) to develop a high-fidelity, interactive pressure injury simulation product addressing assessment and treatment disparities in patients with darkly pigmented skin. The recipient will create a mannequin-based simulation system leveraging 3D anatomy printing to represent adjustable skin tones and all stages of pressure injury wounds and variations. Phase...
- The National Heart, Lung, and Blood Institute awarded MDC Studio, Inc. $309,813 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop an automated vascular access device that enables less-experienced providers to safely and reliably perform central venous and arterial cannulation. The R61 phase focuses on automating the core steps of successful cannulation. MDC Studio will design, construct, and test sensors and automation to detect blood vessel...
- The National Heart, Lung, and Blood Institute awarded Minnesota Healthsolutions Corporation $329,537 on August 15, 2026, to develop a novel balloon angioplasty inflation device under the Cardiovascular Diseases Research program (CFDA 93.837). The recipient will design and evaluate a prototype inflation device intended to improve safety and efficacy during percutaneous balloon angioplasty by accounting for molecular composition and elasticity differences in arterial tissue. Current market devices...
- The National Heart, Lung, and Blood Institute awarded Weill Medical College of Cornell University $100,805 on August 17, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop translational extended reality (XR) and artificial intelligence technologies integrated with dynamic soft robotic hearts for immersive clinical training and intraoperative guidance in interventional cardiology. The project addresses critical limitations in structural heart intervention procedures...
- The National Heart, Lung, and Blood Institute awarded Northwestern University $914,694 on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a multi-site study evaluating simulation-based mastery learning for ventricular assist device self-care training. The SIMVAD trial will assess the effectiveness and implementation of simulation-based mastery learning (SBML) across eight ventricular assist device implant centers. VAD patients and caregivers require...
- The National Heart, Lung, and Blood Institute awarded Linshom Medical, Inc. $322,277 on September 10, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct clinical evaluation of an alarm-activated detection system for early intervention of emerging respiratory decline using Linshom's FDA-cleared Continuous Predictive Respiratory Sensor (CPRS). The funding supports clinical development activities demonstrating the health economic value of the CPRS system, which...
- The National Heart, Lung, and Blood Institute awarded Lazarus 3D, Inc. $400,016 on September 10, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate PRE-SURE-CHD, a patient-specific preoperative surgical rehearsal and planning platform for congenital heart defects using 3D printing technology. The project develops synthetic materials that replicate the mechanical properties of cardiac tissue, creates patient-specific 3D-printed prototypes informed by CT...
- The National Institute of Allergy and Infectious Diseases awarded Innovative Design Labs Inc. $313,110 on August 19, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop an automated assessment system for sterile procedure training on mannequin simulations. The project will create hardware, sensing technology, and artificial intelligence models to objectively evaluate aseptic and sterile technique training that currently relies on manual, in-person instructor...